Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Andrew Bonham is active.

Publication


Featured researches published by Andrew Bonham.


Journal of The American College of Surgeons | 1999

Hepatic Resection for Metastatic Colorectal Adenocarcinoma: A Proposal of a Prognostic Scoring System

Shunzaburo Iwatsuki; Igor Dvorchik; Juan Madariaga; J. Wallis Marsh; Forrest Dodson; Andrew Bonham; David A. Geller; Timothy Gayowski; John J. Fung; Thomas E. Starzl

BACKGROUND Hepatic resection for metastatic colorectal cancer provides excellent longterm results in a substantial proportion of patients. Although various prognostic risk factors have been identified, there has been no dependable staging or prognostic scoring system for metastatic hepatic tumors. STUDY DESIGN Various clinical and pathologic risk factors were examined in 305 consecutive patients who underwent primary hepatic resections for metastatic colorectal cancer. Survival rates were estimated by the Cox proportional hazards model using the equation: S(t) = [So(t)]exp(R-Ro), where So(t) is the survival rate of patients with none of the identified risk factors and Ro = 0. RESULTS Preliminary multivariate analysis revealed that independently significant negative prognosticators were: (1) positive surgical margins, (2) extrahepatic tumor involvement including the lymph node(s), (3) tumor number of three or more, (4) bilobar tumors, and (5) time from treatment of the primary tumor to hepatic recurrence of 30 months or less. Because the survival rates of the 62 patients with positive margins or extrahepatic tumor were uniformly very poor, multivariate analysis was repeated in the remaining 243 patients who did not have these lethal risk factors. The reanalysis revealed that independently significant poor prognosticators were: (1) tumor number of three or more, (2) tumor size greater than 8 cm, (3) time to hepatic recurrence of 30 months or less, and (4) bilobar tumors. Risk scores (R) for tumor recurrence of the culled cohort (n = 243) were calculated by summation of coefficients from the multivariate analysis and were divided into five groups: grade 1, no risk factors (R = 0); grade 2, one risk factor (R = 0.3 to 0.7); grade 3, two risk factors (R = 0.7 to 1.1); grade 4, three risk factors (R= 1.2 to 1.6); and grade 5, four risk factors (R > 1.6). Grade 6 consisted of the 62 culled patients with positive margins or extrahepatic tumor. Kaplan-Meier and Cox proportional hazards estimated 5-year survival rates of grade 1 to 6 patients were 48.3% and 48.3%, 36.6% and 33.7%, 19.9% and 17.9%, 11.9% and 6.4%, 0% and 1.1%, and 0% and 0%, respectively (p < 0.0001). CONCLUSIONS The proposed risk-score grading predicted the survival differences extremely well. Estimated survival as determined by the Cox proportional hazards model was similar to that determined by the Kaplan-Meier method. Verification and further improvements of the proposed system are awaited by other centers or international collaborative studies.


Liver Transplantation | 2003

Orthotopic Liver Transplantation in Patients With Human Immunodeficiency Virus and End-Stage Liver Disease

Guy W. Neff; Andrew Bonham; Andreas G. Tzakis; Margaret V. Ragni; Dushyantha Jayaweera; Eugene R. Schiff; Obaid Shakil; John J. Fung


Hepatology | 2003

Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma

Sydney D. Finkelstein; Wallis Marsh; Anthony J. Demetris; Patricia A. Swalsky; Eizaburo Sasatomi; Andrew Bonham; Michael Subotin; Igor Dvorchik


Hepatology | 2001

Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: Biologic and therapeutic implications

Hale Kirimlioglu; Igor Dvorchick; Kris Ruppert; Sydney D. Finkelstein; J. Wallis Marsh; Shunzaburo Iwatsuki; Andrew Bonham; Brian I. Carr; Michael A. Nalesnik; George K. Michalopoulos; Thomas E. Starzl; John J. Fung; Anthony Jake Demetris


Seminars in Liver Disease | 2000

Posttransplantation: future therapies.

Marion G. Peters; Daniel Shouval; Andrew Bonham; John M. Vierling; Anna S. Lok


Transplantation | 2008

Study Of Complete Immunosuppressive Drug Withdrawal From Liver Transplant Patients Conditioned With Posttransplant Total Lymphoid Irradiation (tli) And Anti-thymocyte Globulin (atg): 212

Andrew Bonham; Carlos O. Esquivel; Waldo Concepcion; Samuel Strober


Transplantation | 2000

ADMINISTRATION OF A NEW SUBSET OF DENDRITIC CELLS PROPAGATED FROM MOUSE LIVERS PROLONGS CARDIAC ALLOGRAFT SURVIVAL BY DIFFERENTIATION OF T REGULATORY CELLS.: Abstract# 1094

Lina Lu; Shiguang Qian; Xiaoyan Liang; Zongyou Chen; Wei Li; Michael A. Nalesnik; Liangfu Wang; Andrew Bonham; John J. Fung


Transplantation | 2000

HBIG AND LAMIVUDINE AFTER LIVER TRANSPLANTATION FOR HEPATITIS B RELATED LIVER DISEASE.: Abstract# 767 Poster Board #-Session: P24-III

S. F. Dodson; Vijayan Balan; Obaid Shakil; Andrew Bonham; John J. Fung


Transplantation | 2018

Combined En-Bloc Heart Liver Transplantation in Children with Congenital Heart Disease Complicated by Cardiac Cirrhosis

Sarah Conlon; Katsuhide Maeda; Olaf Reinhartz; Seth A. Hollander; David N. Rosenthal; Amy Gallo; Waldo Concepcion; Carlos O. Esquivel; Andrew Bonham


European Journal of Gastroenterology & Hepatology | 2003

Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease

Guy W. Neff; Andrew Bonham; Andreas G. Tzakis; Margaret V. Ragni; Dushyantha Jayaweera; Eugene R. Schiff; Obald Shakil; John J. Fung

Collaboration


Dive into the Andrew Bonham's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Guy W. Neff

University of Cincinnati

View shared research outputs
Top Co-Authors

Avatar

Igor Dvorchik

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lina Lu

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge